- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02612805
The Diabetes and Aquatic Training Study (DATS) (DATS)
Effects of Two Models of Physical Training in Aquatic Environment in Control of Type 2 Diabetes - A Controled Randomized Clinical Trial: The Diabetes and Aquatic Training Study (DATS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The fact that aquatic training can provide similar benefits to land training has important clinical implications, because the aquatic environment provides some interesting advantages to this population, such as no impact on walking and running in deep water or reduced, as in water-based exercises. This minor impact and consequent reduced chance of injury allows consider the aquatic environment favorable to the principle of continuity with progression of physiological stimuli and metabolic benefits.
From these peculiarities of the training in aquatic environment, and of the association between T2DM with obesity and hypertension, conditions that create difficulties for individuals performing exercise supporting their own body mass and need both benefits from aerobic and resistance training, is believed to be necessary to carry out physical training programs of the same duration, differing in training mode (aerobic or combined) in the aquatic environment in order to answer of in a adequated duration of training, the diabetes control through training differs between the different mode of exercise.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 2 diabetes;
- Be under medical treatment with oral hypoglycemic agents and / or insulin;
- Not engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week).
Exclusion Criteria:
- Severe autonomic neuropathy;
- Severe nonproliferative and proliferative diabetic retinopathy;
- Decompensated heart failure;
- Limb amputations;
- Severe foot injuries;
- Chronic renal failure (Modification Diet in Renal Disease-MDRD, Glomerular Filtration Rate-GFR < 30 ml/min);
- Body mass index (BMI) > 45.0 kg/m2;
- Any muscle or joint impairment which prevented individuals from engaging in physical exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aerobic training group
This group perform aerobic hydrogymnastics.
|
Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Method of training: Aerobic continuous in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: 85% to 100% of the anaerobic threshold during the intervention.
Other Names:
|
|
Active Comparator: Combined training group
This group perform combined hydrogymnastics.
|
Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Method of training: Aerobic more resistance training. Aerobic component (between 30 and 40 minutes of the sessions): Method: Aerobic continuous in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: 85% to 100% of the anaerobic threshold during the intervention. Resistance component (Between 10 and 20 minutes of the sessions): Method: Multiple sets (2 to 4 sets of 30 to 15 seconds) in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: Maximum execution speed.
Other Names:
|
|
Placebo Comparator: Training placebo
This group perform stretching and relaxation in aquatic environment.
|
Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Activities performed in main part: Stretching and relaxation in aquatic environment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in levels of glycated hemoglobin
Time Frame: Change from Baseline levels of glycated hemoglobin at 15-weeks.
|
Change from Baseline levels of glycated hemoglobin at 15-weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fasting plasma glucose.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Fasting insulin.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Insulin-resistance index (HOMA-IR).
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Total cholesterol.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
high density lipoprotein.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Low density lipoprotein.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Triglycerides.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Renin
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
High sensitive C-reactive protein.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Total testosterone.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Cortisol
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Testosterone/cortisol ratio.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Peak oxygen uptake.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Oxygen uptake at the second ventilatory threshold.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Percentage of oxygen consumption in the second ventilatory threshold from the peak oxygen uptake.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Systolic blood pressure.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Diastolic blood pressure
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Heart rate at rest.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Maximum dynamic muscle strength (1RM) in the knees extension exercise.
Time Frame: At baseline and after a 15-week period.
|
The test is characterized by greater load that can be supported in a single execution of knees extension exercise.
|
At baseline and after a 15-week period.
|
|
Maximum dynamic muscle strength (1RM) in the elbows flexion exercise.
Time Frame: At baseline and after a 15-week period.
|
The test is characterized by greater load that can be supported in a single execution of elbows flexion exercise.
|
At baseline and after a 15-week period.
|
|
Resistant dynamic muscle strength (maximal repetitions) in the knees extension exercise.
Time Frame: At baseline and after a 15-week period.
|
To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution.
In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training.
|
At baseline and after a 15-week period.
|
|
Resistant dynamic muscle strength (maximal repetitions) in the elbows flexion exercise.
Time Frame: At baseline and after a 15-week period.
|
To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution.
In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training.
|
At baseline and after a 15-week period.
|
|
Timed up and go test performed at the usual speed.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Timed up and go test performed at the maximal speed.
Time Frame: At baseline and after a 15-week period.
|
At baseline and after a 15-week period.
|
|
|
Sitting-rising test (SRT).
Time Frame: At baseline and after a 15-week period.
|
The SRT basically consists in the quantification of the number of support (hands and/or knees, or hands or forearms on knees) one utilizes in order to sit and to rise from the floor.
|
At baseline and after a 15-week period.
|
|
Overall quality of life and in physical, psychological, social relationships and environment domains, evaluated by instrument of World Health Organization (WHOQOL).
Time Frame: At baseline and after a 15-week period.
|
To evaluate the quality of life we used the WHOQOL-brief instrument.
This instrument is self-applicable, cross-cultural, translated and validated for Portuguese, consisting of 26 questions.
Its score ranges from zero to 100 points, divided into the physical, psychological, social relationships and environment, as well as an assessment of the overall quality of life.
|
At baseline and after a 15-week period.
|
|
Depressive symptoms, evaluated by Depression Inventory Patient Health Questionnarie (PHQ-9)
Time Frame: At baseline and after a 15-week period.
|
For evaluation of depressive symptoms was used the questionnaire PHQ-9 depression, which consists of nine items, including symptoms and attitudes whose intensity varies from zero to three, with 27 your score.
|
At baseline and after a 15-week period.
|
|
Sleep quality, evaluated by Pittsburgh Sleep Scale
Time Frame: At baseline and after a 15-week period.
|
Sleep quality was assessed by Pittsburgh scale, consisting of 19 questions on the perception of oneself and five questions relating to the perception that the roommates of these individuals have about sleep the same.
These questions are grouped into seven components, with score of zero to three.
|
At baseline and after a 15-week period.
|
|
Levels of sleep Obstructive Apnea, evaluated by Berlin Questionnaire (BQ)
Time Frame: At baseline and after a 15-week period.
|
This questionnaire includes 10 items, organized in 3 categories related to snoring and apneas witnessed (5 items), daytime sleepiness (4 items) and high blood pressure (HTA) / obesity (1 item).
Information on gender, age, height, weight, race neck circumference and is also requested.
The determination of high or low risk to OSAS is based on responses in each category itens.
|
At baseline and after a 15-week period.
|
|
Physical activity levels, evaluated by International Physical Activity Questionnaire (IPAQ) - Short Form.
Time Frame: At baseline and after a 15-week period.
|
The IPAQ short form asks about three specific types of activity undertaken in the three domains introduced above and sitting.
The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous intensity activities; frequency (measured in days per week) and duration (time per day) are collected separately for each specific type of activity.
|
At baseline and after a 15-week period.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ricardo Stein, PhD, Hospital De Clinicas De Porto Alegre
Publications and helpful links
General Publications
- Delevatti RS, Reichert T, Bracht CG, Lisboa SDC, Marson EC, Costa RR, Kanitz AC, Bones V, Stein R, Kruel LFM. Aquatic Aerobic and Combined Training in Management of Type 2 Diabetes: The Diabetes and Aquatic Training Study (DATS): A Randomized Clinical Trial. J Phys Act Health. 2022 Jul 28;19(8):578-587. doi: 10.1123/jpah.2022-0016. Print 2022 Aug 1.
- Delevatti RS, Kanitz AC, Bracht CG, Lisboa SDC, Marson EC, Reichert T, Bones V, Kruel LFM. Effects of 2 Models of Aquatic Exercise Training on Cardiorespiratory Responses of Patients With Type 2 Diabetes: The Diabetes and Aquatic Training Study-A Randomized Controlled Trial. J Phys Act Health. 2020 Sep 29;17(11):1091-1099. doi: 10.1123/jpah.2020-0236.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-0380
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on Aerobic training
-
University of BarcelonaCompleted
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
Hadassah Medical OrganizationCompletedThe Influence of Different Training Regimens on Electrical Stability Following Myocardial InfarctionIschemic Heart Disease | Congestive Heart FailureIsrael
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Riphah International UniversityCompleted
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtCompleted
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Cardenal Herrera UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Duke UniversityCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States